News

Peripartum psychosis is considered a psychiatric emergency. Here is how an interdisciplinary team can provide the best care.

In this time of crisis, it can be easy to feel unmoored. Here are a few celebrations to help keep us grounded.

Are you ready to put the Psychopathology Refracted into 7 Modalities (PRiSM) Scale into practice? Learn more here.

For much of our 155-year history, the United States has been the global leader in research, including in its provision of funding for education and training in science, to the great advantage of itself and the wider world.

Here is an updated ethical oath geared for our time.

We asked our readers if they thought psychiatry is doing enough to address federal doubt. Here's how they responded.

These 3 stories offer a lesson in humility to psychiatry.

On April 7, 2025, the World Health Organization launched a yearlong initiative focused on improving maternal and newborn health.

Are TV shows educating the public about psychiatric medications?

Female offenders in the criminal justice system are more likely to have experienced trauma and are more likely to be diagnosed with conditions such as PTSD and depression compared with male offenders.

Adherence, switching, and quality of life are top concerns in BDI, and schizophrenia.

This club offers educational opportunities for all involved.

What is the difference between worry and anxiety disorders?

Check out 2 bite-sized reviews of books related to mental health.

Does trontinemab represent the next generation of anti-amyloid monoclonal antibodies thanks to Brainshuttle technology? New research looks encouraging.

The Ethics Committee of the American Psychiatric Association has released its 2025 edition of their opinions on the principles of medical ethics. What is our ethical way forward?

Patients with treatment resistant late-life depression are more likely to respond to antidepressants when sleep is sufficient or has improved.

This variable use of official and unofficial psychiatric diagnoses for political reasons leaves us with a conundrum…

Celebrate Psychiatric Times’ 40th anniversary with a look back at some of our previous covers.

Vanda Pharmaceuticals has submitted an NDA for approval of Bysanti for the treatment of acute bipolar I disorder and schizophrenia.

Here’s how we can best stand up to hatred…

Do you want to be featured in a future Special Report? Check out our April theme!

What percentage of 2025 psychiatric pipeline news was positive vs negative? What disease states are most prominently featured in recent research? Learn more in this exclusive article.

LB Pharmaceuticals presented additional positive data from NOVA1 exploring LB-102 in patients with acutely exacerbated schizophrenia, at the 2025 Annual Congress of the Schizophrenia International Research Society.

Spinogenix announced open enrollment for the phase 2 trial of SPG302, the first synaptic regenerative approach to treat schizophrenia with the potential to improve outcomes across all symptom domains.

Yesterday marked a somber National Doctors’ Day…

Here are highlights from this week in Psychiatric Times, including positive clinical trial news for an ADHD treatment and an exclusive interview on the joint statement defending psychotropic medication safety.

In this CME article, learn more about the common neuropsychiatric sequelae of post-acute sequelae of COVID-19, the underlying neurobiological mechanisms, and evidence-based treatments and interventions.

The LGBTQIA+ community has faced marginalization and stereotyping in media, including video games. Let’s examine the intersection of identity, mental health, and video gaming.